Shawn Rose, M.D., Ph.D.

Shawn Rose, M.D., Ph.D.

Chief Medical Officer and Head of Research and DevelopmentatNkarta· In the 2025 proxy

Pay in FY2025Nkarta stock -25.7% the same year

Shawn Rose, M.D., Ph.D. was paid $1.2M in FY2025 (Dec). Nkarta stock fell 25.7% that year.

Pay$100 in the stock at the end of FY24 → $74
Pay is from the Summary Compensation Table of each Nkarta proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NkartaPublic company · 1 yr
    • Chief Medical Officer and Head of Research and Development2025 – Present · 1 yrStock in role -27%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?